These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 326958)

  • 1. Evidence that human leukocyte inhibitory factor (LIF) is an esterase.
    Rocklin RE; Rosenthal AS
    J Immunol; 1977 Jul; 119(1):249-52. PubMed ID: 326958
    [No Abstract]   [Full Text] [Related]  

  • 2. Human leukocyte migration inhibitory factor (LIF). I. Effect of synthetic and naturally occurring esterase and protease inhibitors.
    Bendtzen K
    Scand J Immunol; 1977; 6(1-2):125-31. PubMed ID: 322257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukocyte migration inhibitory factor (LIF). II. Partial biochemical characterization of the substrate specificities for this lymphokine.
    Bendtzen K
    Scand J Immunol; 1977; 6(1-2):133-40. PubMed ID: 322260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human leukocyte migration inhibitory factor (LIF). I. Effect of synthetic and naturally occurring esterase and protease inhibitors.
    Bendtzen K
    Scand J Immunol; 1977; 6(1-2):126-31. PubMed ID: 322258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis.
    Goetzl EJ; Rocklin RE
    J Immunol; 1978 Sep; 121(3):891-6. PubMed ID: 690441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
    Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
    J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the human lymphokine leukocyte migration inhibitory factor (LIF) by a sensitive radioenzymatic assay. Inhibitory effect of cGMP on the esterolytic activity of highly purified LIF.
    Bendtzen K
    J Clin Lab Immunol; 1979 Apr; 2(1):37-43. PubMed ID: 95804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukocyte migration inhibitory factor (LIF). IV. 3',5'-cGMP protects LIF against inactivation by the esterase inhibitor phenylmethylsulfonyl fluoride.
    Bendtzen K
    Scand J Immunol; 1977; 6(12):1357-61. PubMed ID: 203999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inability to block the activity of guinea pig migration inhibitory factor with di-isopropyl phosphorofluoridate.
    David JR; Becker EL
    Eur J Immunol; 1974 Apr; 4(4):287-9. PubMed ID: 4604594
    [No Abstract]   [Full Text] [Related]  

  • 11. Human leukocyte inhibitory factor (LIF): use of benzoyl L-arginine ethyl ester to detect LIF activity.
    Rocklin RE; Urbano AM
    J Immunol; 1978 Apr; 120(4):1409-14. PubMed ID: 347003
    [No Abstract]   [Full Text] [Related]  

  • 12. Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF).
    Rocklin RE
    J Immunol; 1974 Apr; 112(4):1461-6. PubMed ID: 4592603
    [No Abstract]   [Full Text] [Related]  

  • 13. Human leukocyte inhibitory factor (LIF): a lymphocyte mediator with esteratic properties.
    Rocklin R
    Fed Proc; 1978 Nov; 37(13):2743-7. PubMed ID: 710595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of autologous sera in some dermatoses on spontaneous migration of leukocytes and macrophages taken from mouse spleens.
    Miklaszewska M
    Mater Med Pol; 1978; 10(2):101-6. PubMed ID: 359946
    [No Abstract]   [Full Text] [Related]  

  • 15. The enhancement of MIF activity by inhibition of macrophage associated esterases.
    Remold HG
    J Immunol; 1974 Apr; 112(4):1571-7. PubMed ID: 4592606
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental studies on tuberculin hypersensitivity--immunological significance of leucocyte migration inhibitory factor (LIF) and macrophage migration inhibitory factor (MIF) (author's transl)].
    Matsui Y; Oshima S
    Kekkaku; 1979 Jun; 54(6):331-44. PubMed ID: 388018
    [No Abstract]   [Full Text] [Related]  

  • 17. Leucocyte migration inhibitory activity (LMIA) on concanavalin A (Con-A) stimulated human lymphocytes. Comparison of leucocyte migration capillary technique (LMCT), leucocyte migration agarose technique (LMAT), and leucocyte migration fibrinolysis technique (LMFT).
    Coeugniet E; Bendixen G
    Acta Pathol Microbiol Scand C; 1976 Dec; 84C(6):485-8. PubMed ID: 793298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stimulation of phagocytic function by factors inhibiting leukocyte and macrophage migration in humans].
    Gankovskaia LV; Tskhovrebova AZ; Gvozdeva NA; Koval'chuk LV; Cheredeev AN
    Biull Eksp Biol Med; 1986 Aug; 102(8):210-3. PubMed ID: 3527300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactoferrin stimulates the production of leucocyte migration inhibitory factor by human peripheral mononuclear leucocytes.
    Kijlstra A; Broersma L
    Clin Exp Immunol; 1984 Feb; 55(2):459-64. PubMed ID: 6365377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leukocyte migration inhibitory factor (LIF) III. Further investigations on the serine protease nature of this lymphokine and its preference for arginine amides.
    Bendtzen K
    Scand J Immunol; 1977; 6(10):1055-62. PubMed ID: 335493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.